Creatine for the Treatment of Depression
Open accessThe DOI matches its Crossref record; 193 of the 194 references it cites were found in a registry or an index.
Abstract
Depressed mood, which can occur in the context of major depressive disorder, bipolar disorder, and other conditions, represents a serious threat to public health and wellness. Conventional treatments are not effective for a significant proportion of patients and interventions that are often beneficial for treatment-refractory depression are not widely available. There is, therefore, an immense need to identify novel antidepressant strategies, particularly strategies that target physiological pathways that are distinct from those addressed by conventional treatments. There is growing evidence from human neuroimaging, genetics, epidemiology, and animal studies that disruptions in brain energy production, storage, and utilization are implicated in the development and maintenance of depression. Creatine, a widely available nutritional supplement, has the potential to improve these disruptions in some patients, and early clinical trials indicate that it may have efficacy as an antidepressant agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, early evidence indicates that creatine may be used as an adjunctive therapy in the actual management of clinical depression [71,72,73].”
From Creatine Supplementation in Children and Adolescents (2021) · cites this paper as [71]
In the citing paper
“There is some support in human trials that creatine supplementation may affect depression [171,323].”
From Creatine in health and disease (2021) · cites this paper as [323]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Despite the widespread availability and utilization of conventional antidepressants such as the selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), roughly 53% of persons with depression fail to respond to an initial trial of those medications [1], and as much as 3…”
Interplay between Cortical Spreading Depolarization and Seizures
Kramer, D. R., Fujii, T., Ohiorhenuan, I., & Liu, C. Y. (2017) · Stereotactic and Functional Neurosurgery · doi:10.1159/000452841 · Cited by 3,696
An Energy Budget for Signaling in the Grey Matter of the Brain
Attwell, D., & Laughlin, S. B. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200110000-00001 · Cited by 3,543 · cited 1×
“The brain is an energetically demanding organ and accounts for approximately 20% of body energy consumption at rest, even though it accounts for roughly 2% of body mass [11,12].”
Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
Rolfe, D. F., & Brown, G. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.731 · Cited by 2,021 · cited 1×
“The brain is an energetically demanding organ and accounts for approximately 20% of body energy consumption at rest, even though it accounts for roughly 2% of body mass [11,12].”
Reduction of Prefrontal Cortex Glucose Metabolism Common to Three Types of Depression
Baxter, L. R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810030049007 · Cited by 1,320
Epidemiology of depression and diabetes: a systematic review
Roy, T., & Lloyd, C. E. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70004-6 · Cited by 1,229 · cited 1×
“Depression is three times more prevalent in people with type 1 diabetes than in the general population, and twice as common in type 2 diabetes [46].”
Czéh, B., Michaelis, T., Watanabe, T., Frahm, J., de Biurrun, G., van Kampen, M., Bartolomucci, A., & Fuchs, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211427898 · Cited by 1,091 · cited 1×
“These changes were prevented by treatment with tianeptine, a tricyclic antidepressant [25].”
BDNF - a key transducer of antidepressant effects
Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958 · cited 1×
“These intracellular signals have been implicated in the pathogenesis of depression [35,36], potentially because of their effects on synaptic sprouting, mediated by BDNF [37].”
Research works printed but not linked: 3
- Costentin, 2003, Adenosine A2A receptors and depression, Neurology, 61, S82
- Cheng, 2002, Moderate altitude increases suicide deaths, Ann. Emerg. Med., 40, S55
- Renshaw, P.F., Prescot, A., Ongur, D., Huber, R., and Yurgelun-Todd, D. (2012, January 19–22). Suicide and brain chemical changes with altitude. Proceedings of the 6th Biennial Congress of The International Society of Affective Disorders, London, UK.
Cited by
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
New insights into the cellular activities of Fndc5/Irisin and its signaling pathways
Rabiee, F., Lachinani, L., Ghaedi, S., Nasr-Esfahani, M. H., Megraw, T. L., & Ghaedi, K. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00413-3 · Cited by 176
Effects of creatine supplementation on brain function and health
Forbes, S. C., Cordingley, D. M., Cornish, S. M., Gualano, B., Roschel, H., Ostojic, S. M., Rawson, E. S., Roy, B. D., Prokopidis, K., Giannos, P., et al. (2022) · Nutrients · doi:10.3390/nu14050921 · Cited by 145
Novel drug developmental strategies for treatment‐resistant depression
Borbély, É., Simon, M., Fuchs, E., Wiborg, O., Czéh, B., & Helyes, Z. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15753 · Cited by 106
“There are only mild side effects: nausea, diarrhoea, muscle cramps, hypomania/mania, peripheral oedema and increase of serum creatinine level induced by creatine (Hellem et al., 2015; Kious et al., 2019).”
BackgroundJiang, M., Wang, L., & Sheng, H. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14576 · Cited by 111
“23,24 Notably, it has also been found that patients with diabetes have a higher risk of depression, and the co-occurrence of diabetes mellitus and depression may be associated with abnormal glucose metabolism and the subsequent decreased ATP in the brain.”
Background
Metadata
- Authors
- Kious, B. M., Kondo, D. G., & Renshaw, P. F.
- Affiliations
- University of Utah (US)
- Corresponding author
- Kious, Brent M.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2019-08-23
- Volume
- 9
- Issue
- 9
- Pages
- 406
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC6769464
- OpenAlex
- W2969637735
- Cited by
- 74
- References
- 194
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 15 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 9
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Brain and Behavior Research Foundation (NARSAD Young Investigator Grant)
- U.S. Department of Veterans Affairs (I01-CX000812, I01-CX001611)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- creatine, depression, antidepressant treatment, treatment-resistant depression, brain energy metabolism, major depressive disorder, bipolar disorder, dietary supplements
- MeSH terms
- Clinical Studies as Topic, Animals, Bipolar Disorder, Brain, Creatine, Major Depressive Disorder, Energy Metabolism, Humans, Phosphocreatine, Nutritional Support
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Creatine for the Treatment of Depression. https://app.cochat.ai/papers/10.3390/biom9090406
- The paper
- Kious, B. M., Kondo, D. G., & Renshaw, P. F. (2019). Creatine for the Treatment of Depression. Biomolecules. https://doi.org/10.3390/biom9090406
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
